BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bravo-Vázquez LA, Medina-Ríos I, Márquez-Gallardo LD, Reyes-Muñoz J, Serrano-Cano FI, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review. Dig Dis Sci 2023;68:38-53. [PMID: 35507132 DOI: 10.1007/s10620-022-07516-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lu Y, Chai Y, Qiu J, Zhang J, Wu M, Fu Z, Wang Y, Qin C. Integrated omics analysis reveals the epigenetic mechanism of visceral hypersensitivity in IBS-D. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1062630] [Reference Citation Analysis]
2 Dey A, Vaishak K, Deka D, Radhakrishnan AK, Paul S, Shanmugam P, Daniel AP, Pathak S, Duttaroy AK, Banerjee A. Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review. Infection 2023;:1-16. [PMID: 36906872 DOI: 10.1007/s15010-023-02017-8] [Reference Citation Analysis]
3 Guo JG, Rao YF, Jiang J, Li X, Zhu SM. MicroRNA-155-5p inhibition alleviates irritable bowel syndrome by increasing claudin-1 and ZO-1 expression. Ann Transl Med 2023;11:34. [PMID: 36819593 DOI: 10.21037/atm-22-4859] [Reference Citation Analysis]
4 Bravo-Vázquez LA, Frías-Reid N, Ramos-Delgado AG, Osorio-Pérez SM, Zlotnik-Chávez HR, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Transl Oncol 2022;27:101579. [PMID: 36332600 DOI: 10.1016/j.tranon.2022.101579] [Reference Citation Analysis]
5 Maruyama M, Suzuki H, Sakai A. Potential roles of extracellular non–coding RNAs in pain treatment. PAIN RESEARCH 2022;37:89-96. [DOI: 10.11154/pain.37.89] [Reference Citation Analysis]
6 Dong Z, Liao Z, He Y, Wu C, Meng Z, Qin B, Xu G, Li Z, Sun T, Wen Y, Li G. Advances in the Biological Functions and Mechanisms of miRNAs in the Development of Osteosarcoma. Technol Cancer Res Treat 2022;21:15330338221117386. [PMID: 35950243 DOI: 10.1177/15330338221117386] [Reference Citation Analysis]